Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 2, 2011, Pages

  Upmacis, Rita K ^a   Shen, Hao ^b   Benguigui, Lea Esther S Benguigui ^b   Lamon, Brian D ^b   Deeb, Ruba S ^b   Hajjar, Katherine A ^c   Hajjar, David P ^b  

^a PACE UNIVERSITY   (United States)

^b Center of Vascular Biology   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Eicosanoids; Estrogen; Ferric chloride; Inducible nitric oxide synthase

Indexed keywords

FERRIC CHLORIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRITE; PROSTACYCLIN; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; GENE DELETION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOSIS;

ANALYSIS OF VARIANCE; ANIMALS; AORTA; BLOOD COAGULATION; CARDIOMEGALY; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CHLORIDES; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; FERRIC COMPOUNDS; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REGIONAL BLOOD FLOW; SEX FACTORS; THROMBOSIS; TIME FACTORS;

EID: 79961066645     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00667.2010     Document Type: Article

References (48)

1. Binko J, Majewski H. 17-Estradiol reduces vasoconstriction in endothelium- denuded rat aortas through inducible NOS. Am J Physiol Heart Circ Physiol 274: H853-H859, 1998.
2. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75: 77-85, 1996.
3. Calonge N, Petitti DB, DeWitt TG, Gordis L, Gregory KD, Harris R, Isham G, LeFevre ML, Loveland-Cherry C, Marion LN, Moyer VA, Ockene JK, Sawaya GF, Siu AL, Teutsch SM, Yawn BP; US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: US Preventive Services Task Force recommendation statement. Ann Intern Med 150: 396-404, 2009.
4. Deeb RS, Shen H, Gamss C, Gavrilova T, Summers BD, Kraemer R, Hao G, Gross SS, Laine M, Maeda N, Hajjar DP, Upmacis RK. Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol 168: 349-362, 2006.
5. Detmers PA, Hernandez M, Mudgett J, Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock J, Weikel R, Bergstrom JD, Shevell DE, Hermanowski-Vosatka A, Sparrow CP, Chao YS, Rader DJ, Wright SD, Pure E. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 165: 3430-3435, 2000.
6. Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM, FitzGerald GA. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306: 1954-1957, 2004.
7. Evangelista O, McLaughlin MA. Review of cardiovascular risk factors in women. Gend Med 6: 17-36, 2009.
8. Farrehi PM, Ozaki CK, Carmeliet P, Fay WP. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 97: 1002-1008, 1998.
9. Feinbloom D, Bauer KA. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol 25: 2043-2053, 2005.
10. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N, Grp HR. Cardiovascular disease outcomes during 6.8 years of hormone therapy-Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288: 49-57, 2002.
11. Hellman H, Laitinen RS, Kaila L, Jalonen J, Hietapelto V, Jokela J, Sarpola A, Ramo J. Identification of hydrolysis products of FeCl3.6H(2)O by ESI-MS. J Mass Spectrom 41: 1421-1429, 2006.
12. Hewett SJ, Muir JK, Lobner D, Symons A, Choi DW. Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS. Stroke 27: 1586-1591, 1996.
13. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, Hers. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613, 1998.
14. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, ODonnell TF, Korach KS, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 3: 545-548, 1997.
15. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384: 1343-1364, 2003.
16. Kretz CA, Vaezzadeh N, Gross PL. Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol 30: 900-908, 2010.
17. Kuhlencordt PJ, Chen J, Han F, Astern J, Huang PL. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103: 3099-3104, 2001.
18. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric-chloride. Thromb Res 60: 269-280, 1990.
19. Lamon BD, Upmacis RK, Deeb RS, Koyuncu H, Hajjar DP. Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase- 2 induction by inflammatory stimuli. Am J Physiol Heart Circ Physiol 299: H613-H623, 2010.
20. Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 93: 15069-15074, 1996.
21. Li XD, Geary GG, Gonzales RJ, Krause DN, Duckles SP. Effect of estrogen on cerebrovascular prostaglandins is amplified in mice with dysfunctional NOS. Am J Physiol Heart Circ Physiol 287: H588-H594, 2004.
22. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15: 230-350, 1997.
23. Mani AR, Ollosson R, Mani Y, Ippolito S, Moore KP. Heart rate dynamics in iNOS knockout mice. Life Sci 79: 1593-1599, 2006.
24. Marnett LJ, Wright TL, Crews BC, Tannenbaum SR, Morrow JD. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J Biol Chem 275: 13427-13430, 2000.
25. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999.
26. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 60: 210-241, 2008.
27. Moncada S, Higgs A. Mechanisms of disease-the L-arginine nitric-oxide pathway. N Engl J Med 329: 2002-2012, 1993.
28. Nagashima M, Yin ZF, Zhao L, White K, Zhu YH, Lasky N, Halks- Miller M, Broze GJ, Fay WP, Morser J. Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. J Clin Invest 109: 101-110, 2002.
29. Ospina JA, Krause DN, Duckles SP. 17β-Estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 33: 600-605, 2002.
30. Palombo F, Shen H, Benguigui LES, Kazarian SG, Upmacis RK. Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice. Analyst 134: 1107-1118, 2009.
31. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, Mendelsohn ME. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 90: 1087-1092, 2002.
32. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SAA, Howard BV, Johnson KC, Kotchen M, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002.
33. Sachs UJH, Nieswandt B. In vivo thrombus formation in murine models. Circ Res 100: 979-991, 2007.
34. Scott JA, Weir ML, Wilson SM, Xuan JW, Chambers AF, McCormack DG. Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue. Am J Physiol Heart Circ Physiol 275: H2258-H2265, 1998.
35. Siegerink B, Govers-Riemslag JWP, Rosendaal FR, ten Cate H, Algra A. Intrinsic coagulation activation and the risk of arterial thrombosis in young women results from the Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Case-Control Study. Circulation 122: 1854-1861, 2010.
36. Taylor AW, Bruno RS, Traber MG. Women and smokers have elevated urinary F-2-isoprostane metabolites: a novel extraction and LC-MS methodology. Lipids 43: 925-936, 2008.
37. Tseng MT, Dozier A, Haribabu B, Graham UM. Transendothelial migration of ferric ion in FeCl3 injured murine common carotid artery. Thromb Res 118: 275-280, 2006.
38. Upmacis RK. Atherosclerosis: a link between lipid intake protein tyrosine nitration. Lipid Insights 2: 75-88, 2008.
39. Upmacis RK, Crabtree MJ, Deeb RS, Shen H, Lane PB, Benguigui LES, Maeda N, Hajjar DP, Gross SS. Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol 293: H2878-H2887, 2007.
40. Upmacis RK, Deeb RS, Hajjar DP. Oxidative alterations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediat 80: 1-14, 2006.
41. Upmacis RK, Deeb RS, Hajjar DP. Regulation of prostaglandin H2 synthase activity by nitrogen oxides. Biochemistry 38: 12505-12513, 1999.
42. Vodovotz Y, Kwon NS, Pospischil M, Manning J, Paik J, Nathan C. Inactivation of nitric-oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J Immunol 152: 4110-4118, 1994.
43. Wang XK, Xu L. An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb Res 115: 95-100, 2005.
44. White GC. Current status of thrombolytics-the need for better, especially safer, agents. Thromb Res 122: S1-S2, 2008.
45. Wu F, Wilson JX, Tyml K. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integr Comp Physiol 285: R50-R56, 2003.
46. Wu GJ, Lee JJ, Chou DS, Jayakumar T, Hsiao G, Chen WF, Sheu JR. Inhibitory signaling of 17 beta-estradiol in platelet activation. The pivotal role of cyclic AMP-mediated nitric oxide synthase activation. Eur J Pharmacol 649: 140-149, 2010.
47. Zhang R, Bai YG, Lin LJ, Bao JX, Zhang YY, Tang H, Cheng JH, Jia GL, Ren XL, Ma J. Blockade of AT(1) receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats. J Appl Physiol 106: 251-258, 2009.
48. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295: 505-508, 2002.